Endocrinology

Top Story

Omega-3 fatty acid supplementation does not affect insulin resistance in PCOS

July 25, 2016

Women with polycystic ovary syndrome likely receive no benefit from daily omega-3 fatty acid supplementation, according to a meta-analysis of three randomized controlled trials.

“Reducing the levels of serum insulin and increasing insulin sensitivity are considered to be of paramount importance for therapeutic targets in PCOS,” Alirez Sadeghi, of the department of cellular and molecular nutrition at the School of Nutritional Sciences and Dietetics at Tehran University of Medical Sciences, Iran, and colleagues wrote. “Omega-3 fatty acids may lead to insulin sensitivity by producing and secreting anti-inflammatory adipokines, such as adiponectin, and also through reducing inflammation and proinflammatory cytokines. Although it is said that omega-3 fatty acids have positive effects on insulin resistance, various studies have indicated contradictory results.”

Flu vaccination reduces respiratory, CV hospitalizations for patients with diabetes

July 25, 2016
Patients with type 2 diabetes who received influenza vaccination appeared to experience fewer hospitalizations due to respiratory infection or cardiovascular events than…

Lymphocytic thyroiditis yields high prevalence of benign cervical lymph nodes

July 25, 2016
Fewer central neck compartment metastatic lymph nodes and more reactive benign cervical lymph nodes were found in patients with lymphocytic thyroiditis compared with…
FDA News

Orphan drug status granted for therapy to prevent post-transplantation pancreatic islet loss

July 25, 2016
The FDA granted an orphan drug designation to Araim Pharmaceuticals for its Innate Repair Receptor activator ARA 290, according to a press release. ARA 290 is intended…
In the Journals

HPS2-THRIVE analysis: Adding niacin with laropiprant to statin reduced survival, increased costs

July 25, 2016
Quality of life-adjusted survival was reduced and hospital costs rose due to the addition of extended-release niacin with laropiprant to statin-based therapy, according…
More News Headlines »
CME

New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Video
Meeting News Coverage

VIDEO: FLAT-SUGAR investigators continue to explore role of glucose variability in diabetes-related complications

June 13, 2016
More »
Featured
Highlights from ADA

Highlights from ADA

CME Video

Secondary Prevention of Atherothrombotic Events: Current Insights on Advancing Science

This activity is supported by an educational grant from Merck & Co.

Prevention of cardiovascular disease (CVD) is critical in light of its associated mortality, morbidity, and economic…
More »
Current Issues
View the Current Issues
morganatic-roan